Tibet Weixinkang Medicine Co., Ltd. (603676.SS)

CNY 10.26

(-1.25%)

Operating Income Summary of Tibet Weixinkang Medicine Co., Ltd.

  • Tibet Weixinkang Medicine Co., Ltd.'s latest annual operating income in 2023 was 174.96 Million CNY , up 7.6% from previous year.
  • Tibet Weixinkang Medicine Co., Ltd.'s latest quarterly operating income in 2024 Q3 was 89.52 Million CNY , up 53.32% from previous quarter.
  • Tibet Weixinkang Medicine Co., Ltd. reported an annual operating income of 162.6 Million CNY in 2022, up 58.97% from previous year.
  • Tibet Weixinkang Medicine Co., Ltd. reported an annual operating income of 102.28 Million CNY in 2021, up 128.99% from previous year.
  • Tibet Weixinkang Medicine Co., Ltd. reported a quarterly operating income of 58.39 Million CNY for 2024 Q2, down -10.29% from previous quarter.
  • Tibet Weixinkang Medicine Co., Ltd. reported a quarterly operating income of 89.52 Million CNY for 2024 Q3, up 53.32% from previous quarter.

Annual Operating Income Chart of Tibet Weixinkang Medicine Co., Ltd. (2023 - 2013)

Historical Annual Operating Income of Tibet Weixinkang Medicine Co., Ltd. (2023 - 2013)

Year Operating Income Operating Income Growth
2023 174.96 Million CNY 7.6%
2022 162.6 Million CNY 58.97%
2021 102.28 Million CNY 128.99%
2020 44.66 Million CNY -19.11%
2019 55.22 Million CNY -27.95%
2018 76.64 Million CNY -13.56%
2017 88.67 Million CNY -21.75%
2016 113.31 Million CNY -6.17%
2015 120.77 Million CNY -5.07%
2014 127.22 Million CNY 26.18%
2013 100.82 Million CNY 0.0%

Peer Operating Income Comparison of Tibet Weixinkang Medicine Co., Ltd.

Name Operating Income Operating Income Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.25 Billion CNY 94.63%
Yabao Pharmaceutical Group Co., Ltd 226.33 Million CNY 22.697%
Shandong Lukang Pharmaceutical Co.,Ltd. 277.16 Million CNY 36.875%
Zhejiang Huahai Pharmaceutical Co., Ltd. 1.36 Billion CNY 87.16%
Chongqing Taiji Industry(Group) Co.,Ltd 1.17 Billion CNY 85.086%
Tasly Pharmaceutical Group Co., Ltd 1.22 Billion CNY 85.751%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 1.09 Billion CNY 84.05%
Lionco Pharmaceutical Group Co.,Ltd. -148.98 Million CNY 217.44%
Joincare Pharmaceutical Group Industry Co.,Ltd. 3.5 Billion CNY 95.01%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 22.03 Million CNY -693.893%
Shanghai Haoyuan Chemexpress Co., Ltd. 128.32 Million CNY -36.34%
China Animal Husbandry Industry Co., Ltd. 402.76 Million CNY 56.56%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 563.79 Million CNY 68.967%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.17 Billion CNY 85.119%
Zhejiang Shengda Bio-Pharm Co., Ltd. -45.67 Million CNY 483.053%
Harbin Pharmaceutical Group Co., Ltd. 659.62 Million CNY 73.476%
Zhejiang Medicine Co., Ltd. 380.15 Million CNY 53.976%
HPGC Renmintongtai Pharmaceutical Corporation 411.84 Million CNY 57.517%
Humanwell Healthcare (Group) Co.,Ltd. 3.44 Billion CNY 94.924%
Ginwa Enterprise (Group) Inc. -1.69 Million CNY 10422.529%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 169.4 Million CNY -3.28%
KPC Pharmaceuticals, Inc. 568.49 Million CNY 69.223%
Henan Lingrui Pharmaceutical Co., Ltd. 656.3 Million CNY 73.341%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 249.11 Million CNY 29.766%
Ningbo Menovo Pharmaceutical Co., Ltd. 18.74 Million CNY -833.239%
Nanjing Well Pharmaceutical Group Co.,Ltd. 121.77 Million CNY -43.676%
Guizhou Yibai Pharmaceutical Co., Ltd. 145.51 Million CNY -20.239%
Zhongzhu Healthcare Holding Co.,Ltd -135.23 Million CNY 229.376%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 5.12 Billion CNY 96.583%
China National Medicines Corporation Ltd. 2.94 Billion CNY 94.058%
Shenzhen Chipscreen Biosciences Co., Ltd. 97.07 Million CNY -80.241%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 97.08 Million CNY -80.208%
Jianmin Pharmaceutical Group Co.,Ltd. 573.86 Million CNY 69.511%
Beijing Tongrentang Co., Ltd 3.08 Billion CNY 94.327%
North China Pharmaceutical Company Ltd. 540.51 Million CNY 67.63%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 1.51 Billion CNY 88.452%
CanSino Biologics Inc. -1.93 Billion CNY 109.035%
Zhejiang Hisun Pharmaceutical Co., Ltd. 89.44 Million CNY -95.614%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 473.24 Million CNY 63.029%
ChengDu ShengNuo Biotec Co.,Ltd. 81.1 Million CNY -115.735%
Dali Pharmaceuticalco.,Ltd -17.03 Million CNY 1127.067%
Changchun BCHT Biotechnology Co. 559.29 Million CNY 68.717%
Shanghai Jiaoda Onlly Co.,Ltd -25.57 Million CNY 784.113%
Jiang Zhong Pharmaceutical Co.,Ltd 894.11 Million CNY 80.432%
Mayinglong Pharmaceutical Group Co., LTD. 536.62 Million CNY 67.396%
Cisen Pharmaceutical Co., Ltd. 592.57 Million CNY 70.474%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 173.9 Million CNY -0.606%
Hunan Warrant Pharmaceutical Co.,Ltd 237.11 Million CNY 26.212%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 3.3 Billion CNY 94.71%
Hunan Fangsheng Pharmaceutical Co., Ltd. 196.44 Million CNY 10.935%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 132.68 Million CNY -31.863%
Guobang Pharma Ltd. 702.26 Million CNY 75.086%
Shaanxi Kanghui Pharmaceutical Co., Ltd. -61.8 Million CNY 383.101%
Shandong Buchang Pharmaceuticals Co., Ltd. 436.01 Million CNY 59.873%
Zhejiang Starry Pharmaceutical Co.,Ltd. 138.93 Million CNY -25.932%
Kangmei Pharmaceutical Co., Ltd. 86.66 Million CNY -101.882%
Henan Taloph Pharmaceutical Stock Co.,Ltd 44.16 Million CNY -296.145%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 461.93 Million CNY 62.124%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -331.9 Million CNY 152.714%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 194.16 Million CNY 9.888%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.08 Billion CNY 83.824%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.45 Million CNY 10.483%
Tibet Rhodiola Pharmaceutical Holding Co. 899.09 Million CNY 80.54%
Sichuan Huiyu Pharmaceutical Co., Ltd. 124.36 Million CNY -40.681%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 174.77 Million CNY -0.11%